512 — Grand Pharmaceutical Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual income statement for Grand Pharmaceutical, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,353	8,598	9,562	10,530	11,645
Cost of Revenue
Gross Profit	4,035	5,247	5,951	6,524	6,738
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,226	5,833	6,864	7,955	8,761
Operating Profit	2,127	2,765	2,698	2,574	2,884
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	2,074	2,786	2,517	2,344	2,852
Provision for Income Taxes
Net Income After Taxes	1,781	2,405	2,098	1,895	2,466
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,793	2,403	2,079	1,880	2,468
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,793	2,403	2,079	1,880	2,468
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.521	0.685	0.598	0.638	0.704
Dividends per Share